Invention Grant
- Patent Title: Autotaxin inhibitors
-
Application No.: US14906161Application Date: 2014-07-16
-
Publication No.: US09763957B2Publication Date: 2017-09-19
- Inventor: David Beattie , Urs Baettig , Darren Mark Legrand , Andrew Stuart Lister , Jeffrey McKenna , David William Pearce , David Andrew Sandham , Oliver Ross Steward , Christopher Thomson
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Shawn D. Britt
- Priority: EP13177061 20130718
- International Application: PCT/IB2014/063143 WO 20140716
- International Announcement: WO2015/008230 WO 20150122
- Main IPC: A61K31/445
- IPC: A61K31/445 ; A61K31/551 ; C07D403/12 ; C07D401/14 ; C07D413/14 ; A61K31/41 ; A61K31/4245 ; A61K31/427 ; A61K31/5377 ; A61K31/5513 ; C07D401/10 ; C07D401/12 ; C07D403/10 ; C07D403/14 ; C07D407/12 ; C07D413/10 ; C07D413/12 ; C07D417/10 ; C07D417/14 ; C07D257/04 ; A61K45/06 ; A61K31/45 ; A61K31/496 ; A61K31/504 ; A61K31/439 ; A61K31/454 ; A61K31/4545 ; A61K31/506 ; C07D405/12 ; C07D471/08
Abstract:
The present invention relates to novel compounds that are autotaxin inhibitors, processes for their preparation, pharmaceutical compositions and medicaments containing them and to their use in diseases and disorders mediated by autotaxin.
Public/Granted literature
- US20160184318A1 AUTOTAXIN INHIBITORS Public/Granted day:2016-06-30
Information query
IPC分类:
